Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive-Reference-Cited by-同舟云学术

Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive

Published:2022-10-27 Issue:11 Volume:9 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Gudiol Carlota¹²³,Hicklen Rachel S⁴,Okhyusen Pablo C⁵,Malek Alexandre E⁵^ORCID,Kontoyiannis Dimitrios P⁶

Affiliation:

1. Infectious Diseases Department, Bellvitge University Hospital, IDIBIELL, University of Barcelona , Barcelona , Spain

2. Institut Català d’Oncologia , Barcelona , Spain

3. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), (CB21/13/00009), Instituto de Salud Carlos III , Madrid , Spain

4. Research Medical Library, The University of Texas MD Anderson Cancer Center , Houston, Texas , USA

5. Division of Infectious Diseases, LSU Health Shreveport , Shreveport, Louisiana , USA

6. Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center , Houston, Texas , USA

Abstract

Abstract Use of immune checkpoint inhibitors (ICIs), a revolutionary treatment in modern oncology, is frequently complicated by immune-related adverse events (irAEs), which can be confused with infections, and vice versa, thus complicating management decisions. In this study, we review the published cases of infections as simulators of irAEs in cancer patients.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofac570/46649917/ofac570.pdf

Reference32 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

2. Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis;Xu;BMJ,2018

3. Opportunistic infections complicating immunotherapy for non-small cell lung cancer;Liu;Thorac Cancer,2020

4. Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy;Morelli;Thorax,2022

5. CD4 T cells promote rather than control tuberculosis in the absence of PD-1—mediated inhibition;Barber;J Immunol,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of immune checkpoint inhibitors in the development and treatment of infectious processes;Journal of Clinical Practice;2024-04-17

2. PD-L1 expression in keratinocyte and infiltration of CD4 + T lymphocyte can predict a severe type of erythema multiforme major induced by the anti-PD-1 antibody, pembrolizumab;International Cancer Conference Journal;2024-03-29

3. Invasive candidiasis;Nature Reviews Disease Primers;2024-03-21

4. Unintended Consequences: Risk of Opportunistic Infections Associated With Long-term Glucocorticoid Therapies in Adults;Clinical Infectious Diseases;2023-09-06

5. Immune Checkpoint Inhibitors and Infection: What Is the Interplay?;In Vivo;2023